Kynam Capital Management, LP

SEC CIK: 0001907884
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by Kynam Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overview All 13F holders of ALLO Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of ALLO by Kynam Capital Management, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−1,495,981−100.0%	Sold out	Holders
Q1 2023	1,495,981	$7.39M	1.0%	+1,099,603+277.4%	Added	Holders
Q4 2022	396,378	$2.49M	0.4%	+396,378	New	Holders